Genomic Valley Biotech share news and announcements

BSE: 539206Pharmaceuticals & BiotechnologySmall Cap

₹37.71₹1.79 (4.98%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹35.92.

52-week range of traded prices to 23 Oct 2026

₹20.10Low, 29 Jan 2026₹38.20High, 6 Nov 2025

Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
Next results date: the board meets on 30 Oct 2026 to consider: quarterly results.

Market cap: ₹12 Cr4,774th largest listed
P/E: 567.4
P/B: 2.9
Dividend yield: Nonein the last 12 months
ROE: 0.5%
ROCE: 0.8%
Debt to equity: 0.00
Volume, BSE: 2,994

Genomic Valley Biotech share news and announcements

489 announcements, routine notices left out, newest first. Page 9 of 10.

May 2018
- 30 May · Board meeting
  Of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please .... (opens in a new tab)
- 20 May · Management
  This is with reference to captioned subject, we would like to inform you that we have appointed Central Depository Services (India) Limited (CDSL) as Designated Depository for the purpose .... (opens in a new tab)
- 20 May · Intimation Regarding Holding Of Board Meeting On 30.05.2018
  In pursuant of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a Meeting of the Board of Directors of the Company .... (opens in a new tab)
Apr 2018
- 13 Apr · Submission Of Certificate Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31.03.2018
  Please find the enclosed herewith the certificate issued by Mr. Rohit Batham .... (opens in a new tab)
- 10 Apr · Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31.03.2018
  Please find the enclosed herewith the compliance certificate duly signed by .... (opens in a new tab)
- 10 Apr · Statement Of Investor Complaints For The Quarter Ended March 2018
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 10 Apr · Shareholding for the Period Ended March 31, 2018
  Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click ....
Feb 2018
Jan 2018
- 18 Jan · Board Meeting On February 03, 2018
  In pursuant to Reg. 29 of SEBI (LODR) Reg., 2015, Notice is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Saturday, the 03rd February, .... (opens in a new tab)
- 13 Jan · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deepti Aggarwal (opens in a new tab)
- 13 Jan · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amar Aggarwal (opens in a new tab)
- 11 Jan · Submission Of Status Of Investor Complaints Under Regulation 13(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended 31.12.2017
  Status of Investor Complaints for the quarter .... (opens in a new tab)
- 8 Jan · Shareholding for the Period Ended January 06, 2018
  Shareholding Pattern for the Period Ended January 06, 2018. For more details, kindly Click ....
- 8 Jan · Shareholding for the Period Ended December 31, 2017
  Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click ....
Nov 2017
- 23 Nov · Shareholding for the Period Ended November 23, 2017
  Shareholding Pattern for the Period Ended November 23, 2017. For more details, kindly Click ....
- 23 Nov · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Yogesh Agrawal (opens in a new tab)
- 13 Nov · Results
  With reference to the captioned subject and pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, .... (opens in a new tab)
- 13 Nov · Board meeting
  Pursuant to the Reg. 30 and any other applicable regulations of SEBI(LODR) Reg., 2015, please be informed that the Board of Directors at its meeting held on 13th November, 2017, has inter-alia, .... (opens in a new tab)
Oct 2017
- 17 Oct · Submission Of Certificate Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 30.09.2017
  Dear Sir/Madam, Pursuant to the Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the enclosed herewith the certificate .... (opens in a new tab)
- 12 Oct · Submission Of Status Of Investor Complaints Under Regulation 13(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended 30.09.2017
  Dear Sir/Madam, Pursuant to the Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submitting the status of Investor Complaints .... (opens in a new tab)
- 10 Oct · Shareholding for the Period Ended September 30, 2017
  Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click ....
- 10 Oct · Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 30.09.2017
  Please find the enclosed herewith the compliance certificate duly signed by .... (opens in a new tab)
- 10 Oct · Results
  This is with reference to Un-Audited Financial Result (Standalone) for the quarter and year to date ended June 30, 2017 submitted by us on September 13, 2017 and your email dated 06th October, .... (opens in a new tab)
Sep 2017
- 28 Sep · Meeting
  This is to inform you that the 23rd AGM of the Company was held today at 11.00 A.M. at the Reg. Office of the Company situated at 4 K.M. Stone, Berri Chharra Road, P.O. Tandaheri, Teh. .... (opens in a new tab)
- 28 Sep · Results
  Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
- 27 Sep · Meeting
  Dear Sir/Madam, We wish to inform you that the 23rd Annual General Meeting (AGM) of the Company was held today at 11.00 A.M. at the Registered Office of the Company situated at .... (opens in a new tab)
- 13 Sep · Results
  With reference to the captioned subject and pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, .... (opens in a new tab)
- 13 Sep · Board meeting
  Of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please .... (opens in a new tab)
- 13 Sep · Updates
  This is being informed that we have updated our incorporation date in records of Ministry of Corporate Affairs. Due to which, CIN No. of the Company has been changed from 'L01122HR1996PLC033029' .... (opens in a new tab)
- 5 Sep · Meeting
  Register of Members & Share Transfer Books of the Company will remain closed from September 21, 2017 to September 27, 2017 (both days .... (opens in a new tab)
- 4 Sep · Meeting
  This is to inform you that the 23rd Annual General Meeting of the members of Genomic Valley Biotech Limited will be held on Wednesday, 27th day of September, 2017 at 11.00 A.M. at the Registered .... (opens in a new tab)
Aug 2017
Jul 2017
- 12 Jul · Submission Of Status Of Investor Complaints Under Regulation 13(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended 30.06.2017
  Dear Sir/Madam, Pursuant to the Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the status of Investor Complaints .... (opens in a new tab)
- 11 Jul · Results
  Dear Sir/Madam, This has reference to the Audited Financial Result (Standalone) for the quarter and year ended March 31, 2017 submitted by us on May 29, 2017 and your email dated .... (opens in a new tab)
- 7 Jul · Shareholding for the Period Ended June 30, 2017
  Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click ....
May 2017
Apr 2017
- 19 Apr · Submission Of Certificate Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31.03.2017
  Dated: 19th April, 2017 To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort Mumbai-400001 Email ID: [email protected] Ref: Genomic Valley Biotech .... (opens in a new tab)
- 8 Apr · Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31.03.2017
  Dated: 08th April, 2017 To, BSE Limited Ref: Genomic Valley Biotech Limited (539206/ GVBL) Sub: Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, .... (opens in a new tab)
- 7 Apr · Submission Of Status Of Investor Complaints Under Regulation 13(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended 31.03.2017
  Dated: 07th April, 2017 To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort Mumbai-400001 Email ID: [email protected] Ref: Genomic Valley Biotech .... (opens in a new tab)
- 6 Apr · Shareholding for the Period Ended March 31, 2017
  Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....
Feb 2017
- 11 Feb · Results
  1. Standalone Financial Results for the period ended December 31, 2016 2. Standalone Limited Review for the period ended .... (opens in a new tab)
Jan 2017
- 7 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation .... (opens in a new tab)

Genomic Valley Biotech share news and announcements

May 2018

Apr 2018

Feb 2018

Jan 2018

Nov 2017

Oct 2017

Sep 2017

Aug 2017

Jul 2017

May 2017

Apr 2017

Feb 2017

Jan 2017